The evaluation of Nesfatin-1 levels in patients with and without intrauterine growth restriction

References

• American College of Obstetricians and Gynecologists: Clinical Management Guidelines for Obstetricians – Gynecologists. ACOG Practise Bulletin No. 12 American College of Obstetricians and Gynecologists; 2000
   Google Scholar
• Mousa HA, Loughna P. Fetal growth restriction: investigation and treatment. Obstet Gynaecol Reprod Med 2008;18:247–52
   Google Scholar
• Mandruzzato G, Antsaklis A, Botet F, et al. Intrauterine restriction (IUGR). J Perinat Med 2008;36:277–81
   PubMed Web of Science ®Google Scholar
• Cunningham FG, Leveno KL, Bloom SL, et al. Fetal growth disorders. Williams obstetrics, Chapter 38. 22nd ed. New York: McGraw Hill; 2001:893–910
   Google Scholar
• Oh I, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006;443:709–12
   PubMed Web of Science ®Google Scholar
• Aslan M, Celik O, Celik N, et al. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 2012;41:424–9
   PubMed Web of Science ®Google Scholar
• Boutsikou T, Briana DD, Boutsikou M, et al. Cord blood nesfatin-1 concentrations were significantly lower in LGA compared to AGA neonates. Cytokine 2013;61:591–4
   PubMed Web of Science ®Google Scholar
• Stengel A, Goebel M, Wang L, et al. Nesfatin-130-59 but not the N- and C terminal fragments, nesfatin-11-29 and nesfatin-160-82 injected intracerebroventricularly decreases dark phase food intake by increasing inter-meal intervals in mice. Peptides 2012;35:143–8
   PubMed Web of Science ®Google Scholar
• Pałasz A, Krzystanek M, Worthington J, et al. Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides 2012;46:105–112
   PubMed Web of Science ®Google Scholar
• Su Y, Zhang J, Tang Y, et al. The novel function of nesfatin-1: antihyperglycemia. Biochem Biophys Res Commun 2010;391:1039–42
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Tiwari A, Unniappan S. Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun 2009;381:643–8
   PubMed Web of Science ®Google Scholar
• Abizaid A, Gao Q, Horvath TL. Thoughts for food: brain mechanisms and peripheral energy balance. Neuron 2006;51:691–702
   PubMed Web of Science ®Google Scholar
• Shimizu H, Oh-I S, Okada S, Mori M. Nesfatin-1: an overview and future clinical application. Endocr J 2009;56:537–43
   PubMed Web of Science ®Google Scholar
• Stengel A, Goebel M, Tache Y. Nesfatin-1: a novel inhibitory regulator of food intake and body weight. Obes Rev 2011;12:261–71
   PubMed Web of Science ®Google Scholar
• Shimizu H, Ohsaki A, Oh-I S, et al. A new anorexigenic protein, nesfatin-1. Peptides 2009;30:995–8
   PubMed Web of Science ®Google Scholar
• Yosten GL, Redlinger L, Samson WK. Evidence for a role of endogenous nesfatin-1 in the control of water drinking. J Neuroendocrinol 2012;24:1078–84
   PubMed Web of Science ®Google Scholar
• Yosten GL, Samson WK. Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol 2009;297:330–6
   PubMed Web of Science ®Google Scholar
• Price TO, Samson WK, Niehoff ML, Banks WA. Permeability of the blood–brain barrier to a novel satiety molecule nesfatin-1. Peptides 2007;28:2372–81
   PubMed Web of Science ®Google Scholar
• Li Z, Xu G, Li Y, et al. mTOR-dependent modulation of gastric nesfatin-1/NUCB2. Cell Physiol Biochem 2012;29:493–500
   PubMed Web of Science ®Google Scholar
• Maejima Y, Sedbazar U, Suyama S, et al. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 2009;10:355–365
   PubMed Web of Science ®Google Scholar
• Okere B, Xu L, Roubos EW, et al. Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus. Brain Res 2010;1317:92–99
   PubMed Web of Science ®Google Scholar
• Inhoff T, Stengel A, Peter L, et al. Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats. Peptides 2010;31:257–62
   PubMed Web of Science ®Google Scholar
• Zhang AQ, Li XL, Jiang CY, et al. Expression of nesfatin-1/NUCB2 in rodent digestive system. World J Gastroenterol 2010;16:1735–41
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Perry RL, Gao X, et al. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats. Endocrinology 2011;152:3628–37
   PubMed Web of Science ®Google Scholar
• Ramanjaneya M, Chen J, Brown JE, et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depotspecific adipokine with increased levels in obesity. Endocrinology 2010;151:3169–80
   PubMed Web of Science ®Google Scholar
• Aydin S, Dag E, Ozkan Y, et al. Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 2009;328:49–56
   PubMed Web of Science ®Google Scholar
• Li QC, Wang HY, Chen X, et al. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010;159:72–7
   PubMed Web of Science ®Google Scholar
• Garcés MF, Poveda NE, Sanchez E, et al. Regulation of NucB2/Nesfatin-1 throughout rat pregnancy. Physiol Behav 2014;22:216–22
   Web of Science ®Google Scholar
• Zhang C1, Wang Y, Wang Y, et al. Decreased levels of serum nesfatin-1 in patients with preeclampsia. Biomarkers 2014;19:402–6
   PubMed Web of Science ®Google Scholar
• Gungor S, Gurates B, Aydin S, et al. Ghrelins, obestatin, nesfatin-1 and leptin levels in pregnant women with and without hyperemesis gravidarum. Clin Biochem 2013;46:828–30
   PubMed Web of Science ®Google Scholar